Clinical Trials
3
Active:1
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)Phase 2 Combination Study With Escalating Doses of MS1819-SD on Top of a Stable Dose of PPEs
Phase 2
Completed
- Conditions
- Cystic FibrosisCystic Fibrosis of PancreasCystic Fibrosis Gastrointestinal Disease
- First Posted Date
- 2020-03-10
- Last Posted Date
- 2021-08-19
- Lead Sponsor
- AzurRx SAS
- Target Recruit Count
- 20
- Registration Number
- NCT04302662
- Locations
- 🇭🇺
Országos Korányi TBC és Pulmonológiai Intézet Cisztás Fibrózis Részleg, Budapest, Hungary
🇭🇺Borsod-Abaúj-Zemplén Megyei Központi Kórház és Egyetemi Oktatókórház, Gyermekegészségügyi Központ, Miskolc, Hungary
🇭🇺Somogy Megyei Kaposi Mór Oktató Kórház, Mosdósi telephelye Mosdósi Gyermekrehabilitációs és Gyermekpulmonológiai Egység, Mosdós, Hungary
A Phase IIa Study With Escalating Dose of MS1819-SD
Phase 2
Completed
- Conditions
- Chronic PancreatitisDistal Pancreatectomy
- First Posted Date
- 2018-03-29
- Last Posted Date
- 2018-09-28
- Lead Sponsor
- AzurRx SAS
- Target Recruit Count
- 11
- Registration Number
- NCT03481803
- Locations
- 🇦🇺
Mackay Institute of Research and Innovation, Mackay, Queensland, Australia
🇦🇺CMAX, Adelaide, South Australia, Australia
🇦🇺Linear Research, Perth, Western Australia, Australia
News
No news found